Abstract

Chronic heart failure continues to impose a substantial health-care burden, despite recent treatment advances. The key pathophysiological process that ultimately leads to chronic heart failure is cardiac remodelling in response to chronic disease stresses. Here, we review recent advances in our understanding of molecular and cellular mechanisms that play a part in the complex remodelling process, with a focus on key molecules and pathways that might be suitable targets for therapeutic manipulation. Such pathways include those that regulate cardiac myocyte hypertrophy, calcium homoeostasis, energetics, and cell survival, and processes that take place outside the cardiac myocyte--eg, in the myocardial vasculature and extracellular matrix. We also discuss major gaps in our current understanding, take a critical look at conventional approaches to target discovery that have been used to date, and consider new investigational avenues that might accelerate clinically relevant discovery.

Keywords

Heart failureCardiac myocyteMedicineNeuroscienceDiseaseMyocyteCell metabolismCardiac hypertrophyBioinformaticsBiologyCardiologyPathologyInternal medicine

MeSH Terms

AnimalsApoptosisCalciumChronic DiseaseCoronary CirculationExtracellular MatrixHeart FailureHumansMyocytesCardiacSignal TransductionVentricular Remodeling

Affiliated Institutions

Related Publications

Publication Info

Year
2011
Type
review
Volume
378
Issue
9792
Pages
704-712
Citations
282
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

282
OpenAlex
8
Influential
246
CrossRef

Cite This

Ajay M. Shah, Douglas L. Mann (2011). In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. The Lancet , 378 (9792) , 704-712. https://doi.org/10.1016/s0140-6736(11)60894-5

Identifiers

DOI
10.1016/s0140-6736(11)60894-5
PMID
21856484
PMCID
PMC3486638

Data Quality

Data completeness: 90%